Bioactivity | Antituberculosis agent-9 (Compound 5a) is an orally active antitubercular agent with an MIC of 0.5 μg/mL against H37Ra[1]. |
Invitro | Antituberculosis agent-9 (Compound 5a; 48 h) 显示出对 HepG2 细胞的细胞毒性,IC50 值为 3.1 μM[1]。Antituberculosis agent-9 (6 days) 对 MRSA、M. abscessus 和 M. smegmatis 有抑制作用,MIC 均为 4.0 μg/mL[1]。Antituberculosis agent-9 (6 days) 对临床分离的 M. tuberculosis 有抑制作用。对 H37Rv、K4、K12、K5、K16 的 MIC 值分别为 0.5、0.5、0.5、1.0 和 1.0 μg/mL[1]。 |
In Vivo | Antituberculosis agent-9 (Compound 5a; 300 mg/kg; oral; daily for 4 days) 对小鼠有中等抗结核作用[1]。 Animal Model: |
Name | Antituberculosis agent-9 |
Formula | C25H29ClN4O |
Molar Mass | 436.98 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Li C, et al. Structure-Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium tuberculosis. J Med Chem. 2023 Feb 23;66(4):2699-2716. |